BD
BISWAJIT DAS
University of California, Santa Cruz, MITS School of Biotechnology, KIIT School of Biotechnology, Vidyasagar University
About
As a passionate and dedicated researcher, I'm driven to advance cancer biology research, focusing on the molecular mechanisms underlying metastasis and immune evasion by cancer stem cells
Employment
-
University of California, Santa Cruz Postdoctoral Scholar2024 - Present
-
MITS School of Biotechnology Assistant Professor2023 - 2024
-
KIIT School of Biotechnology Project Assistant of a ICMR Funded Project2018 - 2021
-
Midnapore City College Assistant Professor2017 - 2018
Education
-
KIIT School of Biotechnology PhD2020 - 2023
-
Vidyasagar University M.Sc2013 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (25)
- TiO2/graphene oxide-filled carboxymethyl cellulose/chitosan blend films Save
- Synthesis, impurity profiling, simultaneous NP-HPTLC method development, molecular modelling study and EGFR tyrosine kinase inhibitory profile: An integrated approach to characterize desethynyl erlotinib process impurity Save
- Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation Save
- Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents Save
- Generation of Cancer Stem Cells by Co-Culture Methods Save
- Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents Save
- Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells Save
- Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21 Save
- Trigonelline mitigates bleomycin-induced idiopathic pulmonary fibrosis in mice Save
- Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway Save